| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Chen Lei (LC) | Co-Chief Executive Office, Director | FIRST FLOOR, 25 ST STEPHEN'S GREEN, DUBLIN 2, IRELAND | /s/ Chen Lei | 18 Mar 2026 | 0002121050 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | PDD | Options (right to buy) | 18 Mar 2026 | ADSs | 330,000 | Direct | F1, F2, F3 | |||||||
| holding | PDD | Options (right to buy) | 18 Mar 2026 | ADSs | 250,000 | Direct | F2, F3, F4 | |||||||
| holding | PDD | Options (right to buy) | 18 Mar 2026 | ADSs | 13,000,000 | Direct | F2, F3, F5 |
| Id | Content |
|---|---|
| F1 | These options are all exercisable as of the filing date. The expiration date for 80,000 options is August 31, 2036 and the expiration date for the remaining 250,000 options is August 31, 2040. |
| F2 | Each American depositary share ("ADS") of the Issuer represents four (4) Class A ordinary shares. |
| F3 | Each option represents the right to receive, at settlement after exercise, one American Depositary Share ("ADS") of the Issuer, and has an exercise price of US$0.026. |
| F4 | Half of these options will become exercisable on September 1, 2026 and the remaining will become exercisable on September 1, 2027. The expiration date for these options is August 31, 2040. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options. |
| F5 | One-fourth of these options will become exercisable on each of the following dates: November 1, 2027, November 1, 2028, November 1, 2029, and November 1, 2030. The expiration date for these options is October 31, 2043. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options. |